Australia markets closed

AbbVie Inc. (ABBV)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
141.99+3.67 (+2.65%)
At close: 04:03PM EDT
141.41 -0.58 (-0.41%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 237.30B
Enterprise value 300.27B
Trailing P/E 18.98
Forward P/E 11.51
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.16
Price/book (mrq)16.19
Enterprise value/revenue 5.24
Enterprise value/EBITDA 12.22

Trading information

Stock price history

Beta (5Y monthly) 0.69
52-week change 329.88%
S&P500 52-week change 3-13.12%
52-week high 3175.91
52-week low 3106.86
50-day moving average 3140.88
200-day moving average 3146.38

Share statistics

Avg vol (3-month) 35.55M
Avg vol (10-day) 36.84M
Shares outstanding 51.77B
Implied shares outstanding 6N/A
Float 81.77B
% held by insiders 10.11%
% held by institutions 170.75%
Shares short (14 Sept 2022) 412.95M
Short ratio (14 Sept 2022) 42.93
Short % of float (14 Sept 2022) 40.73%
Short % of shares outstanding (14 Sept 2022) 40.73%
Shares short (prior month 14 Aug 2022) 413.01M

Dividends & splits

Forward annual dividend rate 45.64
Forward annual dividend yield 44.20%
Trailing annual dividend rate 35.53
Trailing annual dividend yield 34.00%
5-year average dividend yield 44.31
Payout ratio 476.66%
Dividend date 314 Nov 2022
Ex-dividend date 412 Oct 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 June 2022


Profit margin 22.03%
Operating margin (ttm)33.06%

Management effectiveness

Return on assets (ttm)8.14%
Return on equity (ttm)92.71%

Income statement

Revenue (ttm)57.35B
Revenue per share (ttm)32.39
Quarterly revenue growth (yoy)4.50%
Gross profit (ttm)38.88B
Net income avi to common (ttm)12.57B
Diluted EPS (ttm)7.07
Quarterly earnings growth (yoy)20.60%

Balance sheet

Total cash (mrq)9.96B
Total cash per share (mrq)5.64
Total debt (mrq)73.19B
Total debt/equity (mrq)498.28
Current ratio (mrq)0.84
Book value per share (mrq)8.29

Cash flow statement

Operating cash flow (ttm)22.92B
Levered free cash flow (ttm)18.63B